Inhibition of miR-223 reduces inflammation but not adverse cardiac remodelling after myocardial ischemia-reperfusion in vivo

MLA

Team Medisch, et al. Inhibition of MiR-223 Reduces Inflammation but Not Adverse Cardiac Remodelling after Myocardial Ischemia-Reperfusion in Vivo. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1395291278&authtype=sso&custid=ns315887.

APA

Team Medisch, Team Onderzoek, Regenerative Medicine and Stem Cells, Circulatory Health, Onderzoek Cardiovasculair Reg. Med., Oerlemans, M., van Mil, A., van Eeuwijk, E. C. M., Den Ouden, K., Doevendans, P., & Sluijter, J. (2018). Inhibition of miR-223 reduces inflammation but not adverse cardiac remodelling after myocardial ischemia-reperfusion in vivo.

Chicago

Team Medisch, Team Onderzoek, Regenerative Medicine and Stem Cells, Circulatory Health, Onderzoek Cardiovasculair Reg. Med., Mifj Oerlemans, A van Mil, et al. 2018. “Inhibition of MiR-223 Reduces Inflammation but Not Adverse Cardiac Remodelling after Myocardial Ischemia-Reperfusion in Vivo.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1395291278&authtype=sso&custid=ns315887.